4 results about "Stenocardias" patented technology

Provided herein are pharmaceutical compositions, therapeutic combinations, devices and methods for treating, ameliorating, reversing, causing the remission of, and / or preventing (acting as a prophylaxis, or preventing the initiation of) an inflammatory bowel disorder (IBD) or inflammatory bowel disease (IBD), Ulcerative Colitis; Crohn's disease; J-pouch; fistulising Crohn's disease; a Colitis which can be microscopic, lymphocytic or collagenous; an eosinophilic colitis; indeterminate colitis; idiopathic colitis; diverticulosis and diverticulitis; relapsing diverticulitis; constipation associated inflammatory bowel disease and / or small intestinal bacterial overgrowth; Irritable Bowel Syndrome (IBS) with or without diarrhoea, constipation or pain predominant IBS; periodontitis; rheumatoid arthritis; respiratory infections, appendicitis, vascular disorders such as thrombophlebitis; bacteremia; osteomyelitis; septic shock; Alzheimer's disease; Lemierre syndrome (postanginal sepsis); colonic polyps or adenomas (optionally hyperplastic, adenomatous or serrated adenomas) or preventing the growth of colonic polyps or adenomas, bowl cancer, or metastases (optionally preventing the initiation or promotion of bowl cancer or metastasis); pharyngitis; otitis; sinusitis; and any disease, symptom or condition caused or exacerbated by a Fusobacteria (optionally, a F. nucleatum or F. varium) infection. In alternative embodiments, pharmaceutical compositions comprise rifaximin alone or in combination with other antibiotics or drugs.

The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels. Aqueous solutions including salts of the instant invention are formulated for nasal administration and provide a novel therapeutic platform for the treatment of stable angina, migraine, and cardiac arrhythmia, such as paroxysmal supraventricular tachycardia.

The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels. Aqueous solutions including salts of the instant invention are formulated for nasal administration and provide a novel therapeutic platform for the treatment of stable angina, migraine, and cardiac arrhythmia, such as paroxysmal supraventricular tachycardia.

The utility model belongs to the technical field of medicine storage tools, and particularly relates to a wrist strap medicine storage device which comprises a first bandage, one end of the first bandage is fixedly connected with a connecting pad, one side of the connecting pad is fixedly connected with a second bandage, a medicine storage assembly is fixed to the top of the connecting pad, and the medicine storage assembly comprises a fixed plate, a rotating plate and tablets. When a patient suffers from stenocardia and needs to take medicine, the rotating plate can be rotated, the medicine suction opening is aligned with the medicine storage groove, then the patient can suck the medicine into the inner side of the oral cavity with the mouth facing the medicine suction opening, one hole corresponds to one tablet, and the situation that a plurality of tablets are prone to spilling and leaking when the patient takes the medicine is avoided; an extrusion ring is arranged on the inner side of the medicine storage groove and can elastically extrude the tablets, so that the tablets are not prone to falling off when the patient does not take the tablets, meanwhile, the extrusion force of the extrusion ring on the tablets is moderate, the patient can suck out the tablets through the mouth, medicine taking is convenient and stable, and practicability is high.